Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest if you would like updates on the meeting or topic.
Demonstrate Value of Clinically Validated Digital Therapeutics to All Stakeholders & Usher in a New Wave of Commercially Viable Products
Welcome to the Advancing Digital Therapeutics Summit
Harness DTx to Treat, Manage, & Prevent Disease
The Advancing Digital Therapeutics Summit is the only event in 2025 dedicated to navigating the rapidly evolving DTx industry. This summit will gather 60+ leaders from across the digital therapeutics, healthcare and pharmaceutical sectors to accelerate the commercialization and patient adoption of digital therapeutic products.
With 18+ cutting-edge case studies, regulatory discussions, and commercialization strategies, this event will help you overcome the barriers to scaling digital therapeutics, aligning with regulatory frameworks, driving patient engagement, and forming payor partnerships.
As DTx technologies continue to transform healthcare, this year’s summit will showcase the latest innovations in AI integration, novel reimbursement avenues and alternative regulatory pathways to achieve commercial viability.
If your focus is on leveraging DTx for enhanced patient outcomes and commercial success, this summit is a must-attend.
Why Attend?
Gain access to 18+ case studies, regulatory discussions, and commercialization strategies to overcome barriers in scaling digital therapeutics.